{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:29:33Z","timestamp":1788780573337,"version":"build-2803163510"},"reference-count":12,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,10]]},"DOI":"10.1182\/blood-2015-06-650036","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T23:39:06Z","timestamp":1444865946000},"page":"2649-2652","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Dramatic transient improvement of metastatic BRAFV600E-mutated Langerhans cell sarcoma under treatment with dabrafenib"],"prefix":"10.1182","volume":"126","author":[{"given":"Samia","family":"Mourah","sequence":"first","affiliation":[{"name":"Laboratoire de Pharmacologie Biologique, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cite\u0301, Paris, France"},{"name":"INSERM U976, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl","family":"Lorillon","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence de l\u2019Histiocytose Langerhansienne, Service de Pneumologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Meignin","sequence":"additional","affiliation":[{"name":"Service de Pathologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, INSERM UMR_S1165, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Vercellino","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"de Margerie-Mellon","sequence":"additional","affiliation":[{"name":"Service de Radiologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pages","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Dermatologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Goldwirt","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Biologique, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"How-Kit","sequence":"additional","affiliation":[{"name":"Laboratoire de G\u00e9nomique Fonctionnelle, Fondation Jean Dausset-Centre d\u2019Etude du Polymorphisme Humain, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg","family":"Tost","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Epig\u00e9n\u00e9tique, Centre National de Ge\u0301notypage, Commissariat \u00e0 l'\u00e9nergie atomique et aux \u00e9nergies alternatives-Institut de Ge\u0301nomique, Evry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9leste","family":"Lebbe","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Dermatologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cite\u0301, Paris, France"},{"name":"INSERM U976, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Tazi","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence de l\u2019Histiocytose Langerhansienne, Service de Pneumologie, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"Equipe de Recherche en Biostatistiques et Epid\u00e9miologie Clinique, INSERM U1153 Centre de Recherche INSERM Epid\u00e9miologie et Statistique Paris Sorbonne Cit\u00e9 (CRESS), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111902570312100_B1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MPH.0000000000000196","article-title":"Langerhans cell sarcoma: case report and review of world literature.","volume":"36","author":"Zwerdling","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019111902570312100_B2","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"17","key":"2019111902570312100_B3","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1158\/1078-0432.CCR-14-0887","article-title":"Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436).","volume":"20","author":"Falchook","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7326","key":"2019111902570312100_B4","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.","volume":"468","author":"Johannessen","year":"2010","journal-title":"Nature"},{"issue":"1","key":"2019111902570312100_B5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","article-title":"The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111902570312100_B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2159-8290.CD-13-0631","article-title":"MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF\/MEK inhibition.","volume":"4","author":"Wagle","year":"2014","journal-title":"Cancer Discov"},{"issue":"2","key":"2019111902570312100_B7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","article-title":"Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.","volume":"65","author":"Go","year":"2014","journal-title":"Histopathology"},{"issue":"16","key":"2019111902570312100_B8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","article-title":"Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.","volume":"83","author":"Idbaih","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"2019111902570312100_B9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111902570312100_B10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations.","volume":"373","author":"Hyman","year":"2015","journal-title":"N Engl J Med"},{"issue":"20","key":"2019111902570312100_B11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.","volume":"371","author":"Larkin","year":"2014","journal-title":"N Engl J Med"},{"issue":"20","key":"2019111902570312100_B12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.","volume":"371","author":"Long","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/24\/2649\/1390050\/2649.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/24\/2649\/1390050\/2649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:57:12Z","timestamp":1574132232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/24\/2649\/34705\/Dramatic-transient-improvement-of-metastatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":12,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-06-650036","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}